Fotios Barkas/ LinkedIn
Sep 1, 2025, 07:37
Fotios Barkas Highlights Key Updates in ESC2025 Dyslipidemia Guidelines
Fotios Barkas, Assistant Professor of Internal Medicine University of Ioannina, shared a noteworthy post on LinkedIn:
“Just released in ESC2025: Updated Dyslipidemia Guidelines
Key highlights:
- CAC Score for risk
- LDL-C cutoffs for LLL initiation
- Bempedoic acid and Evinacumab
- Lp(a) ≥50 mg/dL as a cutoff
- Intensification of LLM post-ACS
- EPA only
- Volanesorsen in FCS, statins in HIV, and anthracyclin-induced cardiotoxicity
- Dietary supplements”
Stay updated with Hemostasis Today.
Bempedoic Acid
CAC Score
Cardiotoxicity
cardiovascular risk
Dietary Supplements
Dyslipidemia Guidelines
EPA
ESC 2025
European Atherosclerosis Society
Evinacumab
Familial Chylomicronemia Syndrome
Health
Hematology
Hemostasis Today
HIV
LDL Cholesterol
Lipid Lowering Therapy
Lipoprotein a
Medicine
Post ACS Management
statins
Volanesorsen
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026
-
Jul 25, 2026, 12:06Christina Hart: New Review on Coagulation Disorders in Philadelphia Chromosome-Negative MPNs
-
Jul 25, 2026, 11:57Leonard Valentino: Excited to Share The New Perspectives on Hemophilic Arthropathy
-
Jul 25, 2026, 11:49Meaghan O’Donnell: Highlighting Global Gaps in Haemophilia Carrier Registration at ISTH 2026
-
Jul 25, 2026, 11:43Emmanuel J Favaloro: Honored with the JTH Distinguished Peer Review Award